Patent application number | Description | Published |
20090167500 | RADIO FREQUENCY ALIGNMENT OBJECT, CARRIAGE AND ASSOCIATED METHOD OF STORING A PRODUCT ASSOCIATED THEREWITH - A carrier apparatus is provided that includes a body and a fastener configured to affix the body to a product. The body includes a radio frequency (RF) transponder tag, or marker for directing inclusion of an RF transponder tag, at a designated location on the body. The apparatus of this aspect further includes a positioning feature configured to position the body, RF transponder tag and affixed product relative to an RF antenna separate from the RF transponder tag. This positioning feature may be configured to position the body, RF transponder tag and affixed product in a manner ensuring approximately at least a predetermined spatial relationship between the RF transponder tag and the antenna or one or more other RF transponder tags located proximate the RF transponder tag. A carriage apparatus and method of storing a product are also provided. | 07-02-2009 |
20110077771 | Unit Dose Packaging And Associated Robotic Dispensing System And Method - A unit dose package is provided that facilitates the automated picking of the package. The unit dose package includes a plurality of individually packaged unit dose medications separated by perforations. The unit dose package also defines a hole that may be located along at least one perforation, such as at an intersection of at least two perforations, to permit the package to be stored by being suspended by a rod. A robotic dispensing system and method are also provided that facilitate the selective dispensation of unit dose packages having different numbers of individually packaged unit dose medications. The system includes first and second storage locations for storing first and second unit dose packages which have different numbers of individually packaged unit dose medication(s). The system also includes a controller to direct picking of the first or second unit dose packages dependant upon a requested number of individually packaged unit dose medication(s). | 03-31-2011 |
20110132163 | SYSTEM, METHOD AND CORRESPONDING APPARATUS FOR SINGULATING A UNIT DOSE BLISTER CARD - An apparatus for singulating unit dose blisters from a blister card including at least two perforations separating unit dose blisters positioned adjacent to each other and extending along a longitudinal length of the blister card is provided. The apparatus may include a perforation determiner and a blister card cutter. The perforation determiner may be configured to generate information indicative of a distance between a first perforation location and a second perforation location of the blister card with respect to perforations extending along a direction substantially perpendicular to the longitudinal length of the blister card and separating unit dose blisters to be singulated. The blister card cutter may be configured to utilize the received information indicative of the distance and the total number of perforations to determine cutting locations for cutting at the first perforation location, the second perforation location and additional perforation locations and enable cutting of each perforation extending substantially perpendicular to the longitudinal length of the blister card responsive to sequential cutting and repositioning operations based on determined cutting locations. | 06-09-2011 |
20140278156 | METHOD AND APPARATUS FOR PREPARING AND MONITORING AN INTRAVENOUS FLUID BAG - An intravenous (IV) fluid monitoring system and method are provided to facilitate notification that a replacement IV fluid bag should be prepared. In this regard, an IV fluid monitoring system includes a bag sensing element carried by an IV fluid bag. The IV fluid monitoring system further includes first and second sensing elements positioned on opposite sides of the IV fluid bag and configured to interact with the bag sensing element. The first and second sensing elements are physically separate from the IV fluid bag. The bag sensing element and the first and second elements are positioned such that a line of sight between at least the first sensing element and the bag sensing element extends through the IV fluid within the IV fluid bag while the IV fluid bag is in a filled state. A method and apparatus are also provided to facilitate preparation of an IV fluid bag. | 09-18-2014 |
20140292476 | APPARATUSES, SYSTEMS, AND METHODS FOR STORING AND DISPENSING MEDICATION PROXIMATE A PATIENT - Provided herein are various apparatuses, systems, and methods for improving the efficiency of medication distribution within a healthcare facility. In particular, embodiments may provide for storing and dispensing medications to an authorized medical person for administration to a patient in a healthcare facility. A storage and dispensing system may include a housing defining a cavity, a door movable between an open and a closed position to provide access to the cavity, two or more receivers disposed within the cavity, a lock to lock the door in the closed position, and a user interface configured to receive a request for medications stored within the cavity. The medications may be configured to be presented to a user in response to a request for the medications, while unrequested medications remain inaccessible. | 10-02-2014 |
Patent application number | Description | Published |
20090093458 | METHODS OF IDENTIFYING ANTI-CANCER AGENTS AND USES THEREOF - The present invention provides methods of identifying and/or detecting anti-cancer agents. The present invention provides methods of identifying and/or detecting compounds that can activate PARP and/or induce necrosis. The present invention also provides for methods of treating cancer in an individual. The present invention also provides kits for identifying and/or detecting anti-cancer agents. | 04-09-2009 |
20110130340 | METHODS OF IDENTIFYING ANTI-CANCER AGENTS AND USES THEREOF - The present invention provides methods of identifying and/or detecting anti-cancer agents. The present invention provides methods of identifying and/or detecting compounds that can activate PARP and/or induce necrosis. The present invention also provides for methods of treating cancer in an individual. The present invention also provides kits for identifying and/or detecting anti-cancer agents. | 06-02-2011 |
20110301153 | METHODS OF TREATING CANCER - The invention concerns methods of treating cancer comprising contacting said tumors with a chemical inhibitor of glutaminolysis. These inhibitors include amino-oxyacetate, phenylbutyrate, phenylacetate, and 3,7-bis(dimethylamino)-phenazathionium chloride (methylene blue). | 12-08-2011 |
20120114676 | METHODS OF TREATING CANCER WITH PHENFORMIN - Methods of using phenformin to treat certain types of cancers are described. | 05-10-2012 |
20120288444 | SINGLE DIASTEREOMERS OF 4-FLUOROGLUTAMINE AND METHODS OF THEIR PREPARATION AND USE - The present invention is directed single diasteromers of 4-fluoroglutamine having a diastereomeric excess of at least 80%. Methods of preparing the single diastereomers are also described, as well as methods of using the single diastereomers of radiolabeled 4-fluoroglutamine as imaging agent is also described. | 11-15-2012 |
Patent application number | Description | Published |
20080269259 | Regulation of Autophagy and Cell Survival - Methods of treating an individual who has been identified as having glycolysis dependent cancer are disclosed. The methods comprise the step of: administering to such an individual a combination of an anti-cancer composition that renders the cancer incapable of glycolysis and an autophagy inhibitor. Pharmaceutical compositions and kits comprising that renders the cancer incapable of glycolysis and an autophagy inhibit are also disclosed. Methods of treating an individual who has a disease characterized b cell degeneration and cell death due to autophagy are disclosed. The methods comprise administering to the individual a permeable form of a metabolic substrate that can be oxidized in the tricarboxylic acid cycle to produce NADH. Methods for identifying an autophagy inhibitor comprising performing a test assay using an apopto sis-resistant cell are disclosed. | 10-30-2008 |
20080305092 | Methods of treating autoimmune disease via CTLA-4IG - The method of immunotherapy of the present invention involves the regulation of the T cell immune response through the activation or suppression/inactivation of the CD28 pathway. Induction of activated T cell lymphokine production occurs upon stimulatory binding of the CD28 surface receptor molecule, even in the presence of conventional immunosuppressants. Inhibition of CD28 receptor binding to an appropriate stimulatory ligand or inactivation of the CD28 signal transduction pathway through other means down-regulates CD28-pathway related T cell lymphokine production and its resulting effects. | 12-11-2008 |
20090155836 | METHODS FOR TREATING HIV INFECTED SUBJECTS - Methods for inducing a population of T cells to proliferate by activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand which binds the accessory molecule are described. T cell proliferation occurs in the absence of exogenous growth factors or accessory cells. T cell activation is accomplished by stimulating the T cell receptor (TCR)/CD3 complex or the CD2 surface protein. To induce proliferation of an activated population T cells, an accessory molecule on the surface of the T cells, such as CD28, is stimulated with a ligand which binds the accessory molecule. The T cell population expanded by the method of the invention can be genetically transduced and used for immunotherapy or can be used in methods of diagnosis. | 06-18-2009 |
20120129810 | COMBINATION ANTINEOPLASTIC THERAPY - The present invention is directed to methods of using a sirolimus drug and chloroquine or a quinoline derivative in combination. Methods of use are also described. | 05-24-2012 |
Patent application number | Description | Published |
20100045175 | ORGANIC LIGHT EMITTING DIODE LIGHTING DEVICES - An organic light emitting diode (OLED) device includes a substrate, an anode, a cathode, an active region including an organic material, wherein the active region is electrically coupled to the anode and the cathode, at least one coupler configured to electrically couple at least one of the anode or the cathode to a power supply, and an encapsulation that isolates the active region from an ambient environment. A lighting system can be made including a plurality of OLED devices. A lighting system can be assembled using the OLED devices from a kit. The OLED devices may be polymer light emitting diode (PLED) devices or small molecule light emitting diode (SMOLED) devices. The OLED devices can use regio-regular poly-thiophene. | 02-25-2010 |
20100045189 | ORGANIC LIGHT EMITTING DIODE LIGHTING SYSTEMS - A lighting system includes a plurality of organic light emitting diode (OLED) devices. By selecting the plurality of OLED devices, or by selectively controlling the plurality of OLED devices, the color characteristics of the lighting system can be tuned. The lifetime of the lighting system can be improved. | 02-25-2010 |
20100046210 | ORGANIC LIGHT EMITTING DIODE PRODUCTS - A plurality of organic light emitting diode (OLED) devices can be spatially distributed to form various lighting systems and luminaires. The lighting systems can be configured to readily replace conventional light bulbs or tubular fluorescent lamps. A networked lighting system including a plurality of OLED devices can have a variable light field based on a feedback. | 02-25-2010 |
20120320574 | Organic Light Emitting Diode Products - A plurality of organic light emitting diode (OLED) devices can be spatially distributed to form various lighting systems and luminaires. The lighting systems can be configured to readily replace conventional light bulbs or tubular fluorescent lamps. A networked lighting system including a plurality of OLED devices can have a variable light field based on a feedback. | 12-20-2012 |
20130076263 | ORGANIC LIGHT EMITTING DIODE LIGHTING SYSTEMS - A lighting system includes a plurality of organic light emitting diode (OLED) devices. By selecting the plurality of OLED devices, or by selectively controlling the plurality of OLED devices, the color characteristics of the lighting system can be tuned. The lifetime of the lighting system can be improved. | 03-28-2013 |
20130189805 | ENCAPSULATION FOR ORGANIC OPTOELECTRONIC DEVICES - An organic optoelectronic device includes a substrate, an anode, a cathode, an active region comprising an organic material, an encapsulation that isolates the active region from an ambient environment, wherein the encapsulation comprises a housing, and a first hermetically sealed electrical path through the housing. | 07-25-2013 |
20130334504 | ORGANIC LIGHT EMITTING DIODE LIGHTING DEVICES - An organic light emitting diode (OLED) device includes a substrate, an anode, a cathode, an active region including an organic material, wherein the active region is electrically coupled to the anode and the cathode, at least one coupler configured to electrically couple at least one of the anode or the cathode to a power supply, and an encapsulation that isolates the active region from an ambient environment. A lighting system can be made including a plurality of OLED devices. A lighting system can be assembled using the OLED devices from a kit. The OLED devices may be polymer light emitting diode (PLED) devices or small molecule light emitting diode (SMOLED) devices. The OLED devices can use regio-regular poly-thiophene. | 12-19-2013 |
Patent application number | Description | Published |
20110185082 | SYSTEMS AND METHODS FOR NETWORK VIRTUALIZATION - In a system for network virtualization in a publish and subscribe middleware architecture, a virtual application executes within an execution module on a computer system, where the virtual application has a virtual address and the computer system has a logical address. A network virtualization module manages message routing for the virtual application and a data forwarding plane performs message routing for the virtual application. A communication interface identifies a correspondence between the virtual address and the logical address during message routing with the data forwarding plane and the virtual application. | 07-28-2011 |
20110231470 | SYSTEMS AND METHODS FOR NETWORK VIRTUALIZATION - Message publish/subscribe systems are required to process high message volumes with reduced latency and performance bottlenecks. The end-to-end middleware architecture proposed by the present invention is designed for high-volume, low-latency messaging by, among other things, reducing intermediary hops with neighbor-based routing, introducing efficient native-to-external and external-to-native protocol conversions, monitoring system performance, including latency, in real time, employing topic-based and channel-based message communications, and dynamically optimizing system interconnect configurations and message transmission protocols. | 09-22-2011 |
20130166681 | SYSTEMS AND METHODS FOR NETWORK VIRTUALIZATION - Message publish/subscribe systems are required to process high message volumes with reduced latency and performance bottlenecks. The end-to-end middleware architecture proposed by the present invention is designed for high-volume, low-latency messaging by, among other things, reducing intermediary hops with neighbor-based routing, introducing efficient native-to-external and external-to-native protocol conversions, monitoring system performance, including latency, in real time, employing topic-based and channel-based message communications, and dynamically optimizing system interconnect configurations and message transmission protocols. | 06-27-2013 |
Patent application number | Description | Published |
20090253475 | System and Method for Providing Real World Value in a Virtual World Environment - A system and a method is provided wherein real world monetary or cash values are placed on virtual world avatars, avatar possessed or avatar purchasable virtual world items, environmental virtual world items and virtual world computer generated non-player characters (NPCs), such as slayable beasts, monsters, creatures, or humanoids. These NPCs or other avatars (i.e., other players' avatars) have the ability to defeat and collect the cash value of avatars and their gear, thus gaining cash value for the NPC or the avatars. This cash value is then winnable by any avatar with the skill to best the NPC or other avatar. In this system and method, a real world cash value of an avatar is established and can be increased or decreased based upon the avatar's interaction with other avatars, the virtual world environment and/or a player's investment of real world cash value. | 10-08-2009 |
20110112662 | SYSTEM AND METHOD FOR PROVIDING REAL WORLD VALUE IN A VIRTUAL WORLD ENVIRONMENT - A system and a method is provided wherein real world monetary or cash values are placed on virtual world avatars, avatar possessed or avatar purchasable virtual world items, environmental virtual world items and virtual world computer generated non-player characters (NPCs), such as slayable beasts, monsters, creatures, or humanoids. These NPCs or other avatars (i.e., other players' avatars) have the ability to defeat and collect the cash value of avatars and their gear, thus gaining cash value for the NPC or the avatars. This cash value is then winnable by any avatar with the skill to best the NPC or other avatar. In this system and method, a real world cash value of an avatar is established and can be increased or decreased based upon the avatar's interaction with other avatars, the virtual world environment and/or a player's investment of real world cash value. | 05-12-2011 |
Patent application number | Description | Published |
20090194987 | METHOD, APPARATUS AND MEDICATION STORAGE DEVICE FOR EFFICIENTLY GENERATING MEDICATION LABELS - A method, apparatus and medication storage device are provided for automatically generating labels for medication receptacles. The labels generated may include information about the medication contained in the receptacle that was both received from a healthcare worker at the time of dispensing the medication (e.g., the name (brand and/or generic) of the medication, the amount dispensed, etc.) and retrieved from a central database or server storing information about a plurality of medications (e.g., medication strength, form, etc.). | 08-06-2009 |
20090210089 | LOCK STATUS NOTIFICATION & NEXT CASE MEDICATION METHOD, APPARATUS AND CORRESPONDING MEDICATION STORAGE DEVICE - A lock status notification method, apparatus and corresponding medication storage device (e.g., mobile medication dispensing cart, medication cabinet, nurse server, etc.) are provided. In order to generate the notification, a computing device operating on the medication storage device may monitor the status of a manual lock associated with one or more drawers of the medication storage device (e.g., through the use of a sensor associated with the lock). A notification may be generated if it is determined that the medication storage device is unlocked at a certain point in time (e.g., when a user is attempting to log off of an application executing on the computing device). At least one of the drawers of the medication storage device may include a next case medication pocket having an automatic lock and in which medications prepared for the next case or procedure in which the user is participating can be securely stored. | 08-20-2009 |
Patent application number | Description | Published |
20090131465 | Synthesis and crystalline forms of melanocortin-4 receptor agonist - The present invention relates to a process for producing crystalline N-[1-((3R)-1′-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-yl]carbonyl}-6-chloro-5-methyl-2,3-dihydrospiro[indene-1,4′-piperidine]-3-yl)-1-methylethyl]acetamide, and novel salts, solvates, hydrates and polymorphs thereof. | 05-21-2009 |
20100081642 | CB-1 RECEPTOR MODULATOR PHARMACEUTICAL FORMULATIONS - The present invention relates to pharmaceutical compositions that stabilize and improve the bioavailability of 3-[(1S)- 1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile. In particular, the present invention relates to pharmaceutical compositions that include 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3 -(5-oxo-4,5-dihydro- 1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methylpropyl]-5-fluorobenzonitrile and at least one pharmaceutical acceptable excipient, such as a mono-, di- or triglyceride. | 04-01-2010 |
Patent application number | Description | Published |
20080241573 | SELF CLEANING ALUMINUM ALLOY SUBSTRATES - Self-cleaning aluminum alloy substrates and methods of making the same are disclosed. In one embodiment, a substrate is provided, the substrate including an aluminum alloy body, an anodic oxide zone having micropores within a surface of the aluminum alloy body, the anodic oxide zone being substantially impermeable to contaminants, and a photocatalytic film located on at least a portion of the anodic oxide zone, wherein the photocatalytic film comprises photocatalytically active semiconductor. In one embodiment, a method is provided, the method including the steps of forming an anodic oxide zone in at least a portion of an aluminum alloy base, forming a photocatalytic film, the photocatalytic film being located on the anodic oxide zone, and sealing the anodic oxide zone with a sealant, wherein, as sealed, the anodic oxide zone is substantially impermeable to contaminants. | 10-02-2008 |
20110284389 | SELF CLEANING ALUMINUM ALLOY SUBSTRATES - Self-cleaning aluminum alloy substrates and methods of making the same are disclosed. In one embodiment, a substrate is provided, the substrate including an aluminum alloy body, an anodic oxide zone having micropores within a surface of the aluminum alloy body, the anodic oxide zone being substantially impermeable to contaminants, and a photocatalytic film located on at least a portion of the anodic oxide zone, wherein the photocatalytic film comprises photocatalytically active semiconductor. In one embodiment, a method is provided, the method including the steps of forming an anodic oxide zone in at least a portion of an aluminum alloy base, forming a photocatalytic film, the photocatalytic film being located on the anodic oxide zone, and sealing the anodic oxide zone with a sealant, wherein, as sealed, the anodic oxide zone is substantially impermeable to contaminants. | 11-24-2011 |
Patent application number | Description | Published |
20090147627 | MULTILAYER BACKING ABSORBER FOR ULTRASONIC TRANSDUCER - A multilayer backing absorber for use with an ultrasonic transducer comprises an elemental multilayer having at least one metal layer and at least one adhesive layer, wherein the backing absorber is adapted to be coupled to a vibrating layer of the ultrasonic transducer. | 06-11-2009 |
20110050039 | MULTILAYER ACOUSTIC IMPEDANCE CONVERTER FOR ULTRASONIC TRANSDUCERS - An impedance conversion layer useful for medical imaging ultrasonic transducers comprises a low impedance polymer layer and a high impedance metal layer. These layers are combined with corresponding thicknesses adapted to provide a function of converting from a specific high impedance to specific low impedance, wherein the polymer layer is at the high impedance side and the metal layer is at the low impedance side. The effective acoustic impedance of the polymer and metal layer combination may be adapted to configure an impedance converter in the same way as a quarter wavelength impedance converter, converting from low impedance to high impedance (metal to polymer) or from a high impedance to low impedance (polymer to metal). This structure may be used for front matching with the propagation medium and back matching with an absorber for ultrasonic transducers. | 03-03-2011 |
20130002094 | MULTILAYER ACOUSTIC IMPEDANCE CONVERTER FOR ULTRASONIC TRANSDUCERS - An impedance conversion layer useful for medical imaging ultrasonic transducers comprises a low impedance polymer layer and a high impedance metal layer. These layers are combined with corresponding thicknesses adapted to provide a function of converting from a specific high impedance to specific low impedance, wherein the polymer layer is at the high impedance side and the metal layer is at the low impedance side. The effective acoustic impedance of the polymer and metal layer combination may be adapted to configure an impedance converter in the same way as a quarter wavelength impedance converter, converting from low impedance to high impedance (metal to polymer) or from a high impedance to low impedance (polymer to metal). This structure may be used for front matching with the propagation medium and back matching with an absorber for ultrasonic transducers. | 01-03-2013 |
20130257226 | SIGNAL RETURN FOR ULTRASONIC TRANSDUCERS - A transducer useful for medical imaging ultrasonic transducers comprises a front impedance matching layer, a piezoelectric array, and a rear layer. The front impedance matching layer may include a return connection region electrically coupled to a distal end of the piezoelectric array and a front metal layer with a return signal portion for routing the return signal from the distal end of the transducer to a flex circuit of the rear layer at a proximal end of the transducer. In an embodiment, the rear layer may include a return connection region that is electrically coupled to the piezoelectric array at a distal end of the transducer and also electrically coupled to the signal return lines of a flex circuit at the distal end of the transducer. | 10-03-2013 |
20140050054 | MULTILAYER BACKING ABSORBER FOR ULTRASONIC TRANSDUCER - A multilayer backing absorber for use with an ultrasonic transducer comprises a plurality of absorber elements, each absorber element having at least one metal layer and at least one adhesive layer, wherein the backing absorber is adapted to be coupled to a vibrating layer of the ultrasonic transducer. | 02-20-2014 |
20140117814 | MULTILAYER ACOUSTIC IMPEDANCE CONVERTER FOR ULTRASONIC TRANSDUCERS - An impedance conversion layer useful for medical imaging ultrasonic transducers comprises a low impedance polymer layer and a high impedance metal layer. These layers are combined with corresponding thicknesses adapted to provide a function of converting from a specific high impedance to specific low impedance, wherein the polymer layer is at the high impedance side and the metal layer is at the low impedance side. The effective acoustic impedance of the polymer and metal layer combination may be adapted to configure an impedance converter in the same way as a quarter wavelength impedance converter, converting from low impedance to high impedance (metal to polymer) or from a high impedance to low impedance (polymer to metal). This structure may be used for front matching with the propagation medium and back matching with an absorber for ultrasonic transducers. | 05-01-2014 |
Patent application number | Description | Published |
20080200129 | Method and apparatus for determining modulation levels that are supported on a channel - A logical channel is configured to match a modulation profile of an active channel. A network element is assigned to the logical channel and a ping request is sent to the network element. A response from the network element is measured, such as measuring the MER. The modulation profile is increased in the logical channel and another ping request is sent to the network element. The response is measured again, and the process is repeated until a non-linearity is detected in the response. The acceptable modulation profiles are indicated before the non-linearity is detected in the response. | 08-21-2008 |
20100157824 | Methods and System for Determining a Dominant Impairment of an Impaired Communication Channel - Methods are described for identifying a dominant impairment on a communication channel impaired by an interference issue. The methods include systematic examination of total power loading, systematic examination of signal power reduction, statistical examination of communication channel noise power, and systematic examination of interleaver effectiveness. Each relates to automatically diagnosing and characterizing distortion-based interference issues by monitoring the performance of a communication channel during a testing procedure. These methods enable a technician or engineer to remotely diagnose distortion-based interference issues relatively quickly without having to use external test equipment and without having to deploy technicians to various locations within the cable plant. A system by which these methods can be implemented is also disclosed. | 06-24-2010 |
20100158093 | Methods and System for Determining a Dominant Impairment of an Impaired Communication Channel - Methods are described for identifying a dominant impairment on a communication channel impaired by an interference issue. The methods include systematic examination of total power loading, systematic examination of signal power reduction, statistical examination of communication channel noise power, and systematic examination of interleaver effectiveness. Each relates to automatically diagnosing and characterizing distortion-based interference issues by monitoring the performance of a communication channel during a testing procedure. These methods enable a technician or engineer to remotely diagnose distortion-based interference issues relatively quickly without having to use external test equipment and without having to deploy technicians to various locations within the cable plant. A system by which these methods can be implemented is also disclosed. | 06-24-2010 |
20110069745 | USING EQUALIZATION COEFFICIENTS OF END DEVICES IN A CABLE TELEVISION NETWORK TO DETERMINE AND DIAGNOSE IMPAIRMENTS IN UPSTREAM CHANNELS - A system estimates impairment contributions for upstream communications in a cable television system. The system receives equalization coefficients used by end devices in the cable television system. The equalization coefficients are used by equalizers to mitigate distortion in upstream channels for the end devices. The system analyzes the coefficients based on impairment thresholds to determine whether impairment problems exist and to identify the types of impairment problems that exist. | 03-24-2011 |
20130051442 | METHOD AND APPARATUS FOR UPDATING EQUALIZATION COEFFICIENTS OF ADAPTIVE PRE-EQUALIZERS - A method and apparatus for updating equalization coefficients of an adaptive pre-equalizer of a network element are provided. The method includes monitoring a communications channel to measure distortion of a communications signal received from the network element and detecting whether a transient impairment is present in the communication signal. When a transient impairment is not detected to be present, a pre-equalization coefficient update is transmitted to the network element. However, when a transient impairment is detected to be present, at least selected ones of the pre-equalization coefficients are scaled before the update is transmitted to the network element or the update is withheld from being transmitted to the network element. An apparatus is also disclosed. | 02-28-2013 |
20140029654 | METHOD AND APPARATUS FOR CHARACTERIZING IMPULSE NOISEAND OPTIMIZING DATA LINK EFFICIENCY - Method and apparatus for characterizing an impulse noise impairment impacting communications over data links of a network are provided. A test signal comprising a bit stream of a predetermined bit sequence and packet size is configured and transmitted over the data links. The test signal is received, and the bit stream of the test signal as transmitted is compared to a bit stream of the test signal as received to identify differences in bit sequence. Thereafter, characteristics of the impulse noise impairment impacting communications between the data links are estimated based on the detected differences in bit sequence. | 01-30-2014 |
20140029655 | METHOD OF CHARACTERIZING IMPAIRMENTS DETECTED BY EQUALIZATION ON A CHANNEL OF A NETWORK - An automated method of characterizing distortion detected by equalization on a channel of a network is provided. Equalization stress of an observed channel equalization response of an end device of the network is estimated, and equalization stress is calculated for a theoretical channel equalization response of the end device mathematically based on the observed channel equalization response and a theoretical removal of a suspected impairment from the network. The above referenced calculating step is separately repeated for each of a plurality of suspected impairments stored in a database of suspected impairments. A highest ranking suspected dominant impairment is determined from the database of suspected impairments such that removal of the highest ranking suspected dominant impairment from the network would provide a greatest reduction of equalization stress of a channel equalization response of the end device. | 01-30-2014 |
20150046964 | CATV Digital Transmission with BandPass Sampling - Methods and systems capable of improving the transmission of data along an upstream path of a Hybrid Fiber-Coaxial Cable Network, from a transmitter in a node to a receiver in a Cable Modem Termination System. | 02-12-2015 |
Patent application number | Description | Published |
20090177518 | Method, system and program product for filling job orders - A method, system and program product are disclosed for filling job orders, the method comprising: creating electronically a respective commitment reservation for each of a plurality of workers, with each respective commitment reservation comprising a commitment for the respective worker to work on a prospective job not yet created, with the prospective job having one or more job parameters; receiving electronically a job order subsequent to the creation of one of the commitment reservations, the job order specifying a job with one or more job parameters; matching the job parameters of the job in the job order to the job parameters in one or more of the commitment reservations to obtain a reservation-job match; and, securing automatically based on the results of the matching step the job in the job order to one of the workers with a commitment reservation. | 07-09-2009 |
20120179617 | METHOD, SYSTEM AND PROGRAM PRODUCT FOR FILLING JOB ORDERS - A method, system and program product are disclosed for filling job orders, the method comprising: creating electronically a respective commitment reservation for each of a plurality of workers, with each respective commitment reservation comprising a commitment for the respective worker to work on a prospective job not yet created, with the prospective job having one or more job parameters; receiving electronically a job order subsequent to the creation of one of the commitment reservations, the job order specifying a job with one or more job parameters; matching the job parameters of the job in the job order to the job parameters in one or more of the commitment reservations to obtain a reservation-job match; and, securing automatically based on the results of the matching step the job in the job order to one of the workers with a commitment reservation. | 07-12-2012 |
Patent application number | Description | Published |
20090253475 | System and Method for Providing Real World Value in a Virtual World Environment - A system and a method is provided wherein real world monetary or cash values are placed on virtual world avatars, avatar possessed or avatar purchasable virtual world items, environmental virtual world items and virtual world computer generated non-player characters (NPCs), such as slayable beasts, monsters, creatures, or humanoids. These NPCs or other avatars (i.e., other players' avatars) have the ability to defeat and collect the cash value of avatars and their gear, thus gaining cash value for the NPC or the avatars. This cash value is then winnable by any avatar with the skill to best the NPC or other avatar. In this system and method, a real world cash value of an avatar is established and can be increased or decreased based upon the avatar's interaction with other avatars, the virtual world environment and/or a player's investment of real world cash value. | 10-08-2009 |
20110112662 | SYSTEM AND METHOD FOR PROVIDING REAL WORLD VALUE IN A VIRTUAL WORLD ENVIRONMENT - A system and a method is provided wherein real world monetary or cash values are placed on virtual world avatars, avatar possessed or avatar purchasable virtual world items, environmental virtual world items and virtual world computer generated non-player characters (NPCs), such as slayable beasts, monsters, creatures, or humanoids. These NPCs or other avatars (i.e., other players' avatars) have the ability to defeat and collect the cash value of avatars and their gear, thus gaining cash value for the NPC or the avatars. This cash value is then winnable by any avatar with the skill to best the NPC or other avatar. In this system and method, a real world cash value of an avatar is established and can be increased or decreased based upon the avatar's interaction with other avatars, the virtual world environment and/or a player's investment of real world cash value. | 05-12-2011 |
Patent application number | Description | Published |
20120129851 | Substituted Quinazoline and Pyrido-Pyrimidine Derivatives - The present application provides novel substituted quinazoline and pyrido-pyrimidine compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating PI3K and/or mTOR activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. Advantageously, these compounds perform as dual PI3K/mTOR inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer. | 05-24-2012 |
20120214809 | Aminoindane Compounds and Use Thereof in Treating Pain - The present application provides novel aminoindane compounds and methods for preparing and using these compounds. These compounds are useful in treating pain and/or itch in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) or (II) and a TRPV 1 receptor activator. In one embodiment, the TRPV 1 receptor activator is lidocaine. | 08-23-2012 |
20130085164 | Imidazole Derivatives - The present application provides novel imidazole compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CPY17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer. | 04-04-2013 |
20130101667 | Cyclohexylamines - The present application provides novel compounds and methods for preparing and using these compounds. These compounds are useful in treating pain, itch, overactive bladder and/or interstitial cystitis in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) and a TRPV1 receptor activator. In one embodiment, the TRPV1 receptor activator is lidocaine. | 04-25-2013 |
20130190492 | SUBSTITUTED QUINAZOLINE AND PYRIDO-PYRIMIDINE DERIVATIVES - The present application provides novel substituted quinazoline and pyrido-pyrimidine compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating PI3K and/or mTOR activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. Advantageously, these compounds perform as dual PI3K/mTOR inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer. | 07-25-2013 |
20140073782 | Substituted Quinazoline and Pyrido-Pyrimidine Derivatives - The present application provides novel substituted quinazoline and pyrido-pyrimidine compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating PI3K and/or mTOR activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the PI3K/AKT/mTOR pathway. Advantageously, these compounds perform as dual PI3K/mTOR inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer. | 03-13-2014 |
20140213552 | CYCLOHEXYLAMINES - The present application provides novel compounds and methods for preparing and using these compounds. These compounds are useful in treating pain, itch, overactive bladder and/or interstitial cystitis in patients by administering one or more of the compounds to a patient. The methods include administering a compound of formula (I) and a TRPV1 receptor activator. In one embodiment, the TRPV1 receptor activator is lidocaine. | 07-31-2014 |